Detalles de la búsqueda
1.
Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma.
J Neurooncol
; 131(1): 185-191, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27844311
2.
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
J Clin Oncol
; 41(2): 198-205, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332179
3.
Predictive power to assist phase 3 go/no go decision based on phase 2 data on a different endpoint.
Stat Med
; 31(9): 831-43, 2012 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22302442
4.
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 7(4): 573-584, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33480963
5.
A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies.
Clin Cancer Res
; 13(2 Pt 1): 532-9, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17255275
6.
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer.
Clin Colorectal Cancer
; 5(4): 257-62, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16356302
7.
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors.
Cancer Chemother Pharmacol
; 74(5): 917-25, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25149088
8.
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.
J Clin Oncol
; 28(7): 1168-74, 2010 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20124186
9.
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Clin Lung Cancer
; 10(4): 252-6, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19632943
10.
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
J Clin Oncol
; 27(28): 4787-92, 2009 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19720897
11.
The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
Stat Med
; 27(28): 5850-60, 2008 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18759373
12.
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.
J Clin Oncol
; 26(10): 1698-704, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18375898
13.
A three-outcome design for randomized comparative phase II clinical trials.
Stat Med
; 26(19): 3525-34, 2007 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17262879
Resultados
1 -
13
de 13
1
Próxima >
>>